SCHEMBL4537540

SCHEMBL4537540

O=C(CC1CCCCN1S(=O)(=O)c1ccccc1C(F)(F)F)NC12CC3CC(CC(C3)C1)C2

nearest known ligand 0.46

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 1/20 0.46
KCNQ1 P51787 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
KMT2A Q03164 4/20 0.40
ALDH1A1 P00352 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
MEN1 O00255 1/20 0.40
GAA P10253 2/20 0.39
EPHX1 P07099 1/20 0.39
BDKRB1 P46663 4/20 0.39
HSD11B1 P28845 1/20 0.38
MCOLN3 Q8TDD5 1/20 0.38
PSMB5 P28074 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4539287 0.97 HCRTR1 (0.48) HCRTR1KCNQ1L3MBTL1KMT2AALDH1A1
SCHEMBL4541277 0.86 HSD11B1 (0.46) KCNQ1KMT2AALDH1A1SMN1; SMN2NPC1
SCHEMBL4537814 0.86 EPHX2 (0.44) KMT2AALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL8067220 0.85 ALDH1A1 (0.54) L3MBTL1KMT2AALDH1A1SMN1; SMN2NPC1
SCHEMBL4541031 0.85 ALDH1A1 (0.54) L3MBTL1KMT2AALDH1A1SMN1; SMN2NPC1
SCHEMBL4541739 0.84 EPHX2 (0.48) HCRTR1KMT2AALDH1A1MEN1EPHX1
SCHEMBL4537242 0.83 NPC1 (0.53) KMT2AALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL4539776 0.83 BRD4 (0.53) ALDH1A1EPHX1BDKRB1
SCHEMBL4541290 0.83 HSD11B1 (0.47) KMT2AALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL4541773 0.83 EPHX2 (0.45) HCRTR1KMT2AALDH1A1SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009070497-A1 SEH AND 11 β-HSD1 INHIBITORS AND THEIR USE SMITHKLINE BEECHAM CORPORATION (US) 2009-06-04 WO claimed
WO-2009070497-A1 SEH AND 11 β-HSD1 INHIBITORS AND THEIR USE SMITHKLINE BEECHAM CORPORATION (US) 2009-06-04 WO disclosed